Related Experiment Videos
The blood-aqueous and blood-brain barriers to permeability
American Journal of Ophthalmology
|April 15, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2001
Update on regulatory review intervals for ophthalmic new drug applications at the United States Food and Drug Administration.
American journal of ophthalmology·2000
Financing new drug development in ophthalmology.
Journal of glaucoma·2000
Comparative irritancy study among retinoid creams and gels.
Journal of cutaneous medicine and surgery·1999
Changing Trends in the Microbiological spectrum and clinical presentation of Postcataract Endophthalmitis over a 23-year period.
American journal of ophthalmology·2026
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics.
American journal of ophthalmology·2026
LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances.
American journal of ophthalmology·2026
Null studies in ophthalmology journals: a large-scale analysis of PubMed indexed research.
American journal of ophthalmology·2026
Voretigene Neparvovec (Luxturna) for Biallelic RPE65-Associated Retinal Dystrophy: Systematic Review.
American journal of ophthalmology·2026
Biomaterials in Retinal Surgery: Engineering the Future.
American journal of ophthalmology·2026
CRISPR/Cas9-Driven Fndc5 Knockout Reveals Augmented Mitochondrial Structural and Dynamic Alterations in Diabetic Nephropathy.
International journal of medical sciences·2026
Chromatin Remodeling Subunit ARID1A Negatively Regulates the Malignant Progression of Gastrointestinal Stromal Tumors by Targeting the MEMO1 Promoter.
International journal of medical sciences·2026
A regulatory network underlying idiopathic pulmonary fibrosis.
Frontiers in immunology·2026